Beth Israel Deaconess — Boston, Connecticut

Beth Israel Deaconess is a clinical research site located in Boston, Connecticut, United States 02215.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Nodule Solitary Pulmonary, Non-small Cell Carcinoma.

Sponsors: Biodesix, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess?

Beth Israel Deaconess has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess conducted?

Beth Israel Deaconess has 1 clinical trials on record, with 1 currently active. Their work covers Nodule Solitary Pulmonary, Non-small Cell Carcinoma.

Is Beth Israel Deaconess accredited by Crixeo Health?

Beth Israel Deaconess has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.